These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20073283)

  • 1. Microbicide research already benefiting thousands--experts.
    Bateman C
    S Afr Med J; 2009 Sep; 99(9):628-30. PubMed ID: 20073283
    [No Abstract]   [Full Text] [Related]  

  • 2. A second chance for microbicides.
    Baleta A
    Lancet; 2007 Jul; 370(9581):17-8. PubMed ID: 17632853
    [No Abstract]   [Full Text] [Related]  

  • 3. The introduction of new antiretroviral-based HIV prevention methods into health systems: an update.
    Daly F
    Reprod Health Matters; 2012 Jun; 20(39):215. PubMed ID: 22789099
    [No Abstract]   [Full Text] [Related]  

  • 4. Preservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial.
    Mureithi MW; Poole D; Naranbhai V; Reddy S; Mkhwanazi NP; Sibeko S; Werner L; Abdool Karim Q; Abdool Karim S; Ndung'u T; Altfeld M;
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):124-7. PubMed ID: 22362152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. After microbicide failures, hope that antiviral approach will gel.
    Padma TV
    Nat Med; 2008 Apr; 14(4):354. PubMed ID: 18391925
    [No Abstract]   [Full Text] [Related]  

  • 6. Reformulated tenofovir gel for use as a dual compartment microbicide.
    Dezzutti CS; Rohan LC; Wang L; Uranker K; Shetler C; Cost M; Lynam JD; Friend D
    J Antimicrob Chemother; 2012 Sep; 67(9):2139-42. PubMed ID: 22581908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse approaches useful for microbicide trials.
    Abdool Karim SS; Abdool Karim Q
    Nature; 2007 Sep; 449(7158):24. PubMed ID: 17805274
    [No Abstract]   [Full Text] [Related]  

  • 8. Test of new vaginal microbicide gel show promise for women.
    AIDS Read; 2008 Apr; 18(4):165-6. PubMed ID: 18467997
    [No Abstract]   [Full Text] [Related]  

  • 9. First real success for anti-HIV gel: a new start for HIV microbicides?
    Ariën KK; Vanham G
    Future Microbiol; 2010 Nov; 5(11):1621-3. PubMed ID: 21133683
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV/AIDS. At last, vaginal gel scores victory against HIV.
    Cohen J
    Science; 2010 Jul; 329(5990):374-5. PubMed ID: 20643914
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV prevention in women: next steps.
    Vermund SH; Van Damme L
    Science; 2011 Jan; 331(6015):284. PubMed ID: 21252332
    [No Abstract]   [Full Text] [Related]  

  • 12. Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies.
    Karim QA; Baxter C; Karim SA
    BJOG; 2014 Oct; 121 Suppl 5(0 5):53-61. PubMed ID: 25335841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing adherence in the CAPRISA 004 tenofovir gel HIV prevention trial: results of a nested case-control study.
    MacQueen KM; Weaver MA; van Loggerenberg F; Succop S; Majola N; Taylor D; Karim QA; Karim SA
    AIDS Behav; 2014 May; 18(5):826-32. PubMed ID: 24647763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission.
    Sepúlveda-Crespo D; Sánchez-Rodríguez J; Serramía MJ; Gómez R; De La Mata FJ; Jiménez JL; Muñoz-Fernández MÁ
    Nanomedicine (Lond); 2015; 10(6):899-914. PubMed ID: 25867856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral chemoprophylaxis: new successes and questions.
    Mayer KH
    Lancet; 2015 Jun; 385(9984):2236-7. PubMed ID: 25769358
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing HIV infection: turning the tide for young women.
    McCoy SI; Watts CH; Padian NS
    Lancet; 2010 Oct; 376(9749):1281-2. PubMed ID: 20851461
    [No Abstract]   [Full Text] [Related]  

  • 17. Tenofovir gel--the new HIV prevention 'banker'?
    Bateman C
    S Afr Med J; 2007 Jul; 97(7):496, 498. PubMed ID: 17805450
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial.
    Sokal DC; Karim QA; Sibeko S; Yende-Zuma N; Mansoor LE; Baxter C; Grobler A; Frolich J; Kharsany AB; Miya N; Mlisana K; Maarshalk S; Karim SS
    Antivir Ther; 2013; 18(3):301-10. PubMed ID: 22914267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretrovirals for HIV prevention: translating promise into praxis.
    Mayer KH
    Lancet; 2011 Jul; 378(9787):206-8. PubMed ID: 21763922
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiretroviral vaginal gel shows promise against HIV.
    Baleta A
    Lancet; 2010 Jul; 376(9738):320. PubMed ID: 20681062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.